100 related articles for article (PubMed ID: 6634770)
21. Phase II evaluation of galactitol in head and neck cancer: a Southwest Oncology Group Study.
Haas CD; Lehane D; Bottomley R
Med Pediatr Oncol; 1983; 11(4):281-3. PubMed ID: 6888328
[TBL] [Abstract][Full Text] [Related]
22. Effect of phase I and II chemotherapeutic agents against human lymphomas heterotransplanted in nude mice.
Sordillo PP; Helson C; Lesser M; Helson L
Oncology; 1983; 40(1):15-7. PubMed ID: 6823403
[TBL] [Abstract][Full Text] [Related]
23. Effect of phenobarbital on the toxicity and antitumor activity of dibromodulcitol and dianhydrogalactitol.
Gáti E; Somfai-Relle S
Arzneimittelforschung; 1982; 32(2):149-51. PubMed ID: 7199919
[TBL] [Abstract][Full Text] [Related]
24. 1,2:5,6-Dianhydrogalactitol in advanced breast cancer.
Hoogstraten B; O'Bryan R; Jones S
Cancer Treat Rep; 1978 May; 62(5):841-2. PubMed ID: 657167
[No Abstract] [Full Text] [Related]
25. Anticancer activity and mechanisms of diacetyldianhydrogalactitol on hepatoma QGY-7703 cells.
Zhang XY; Lian Yan X; Guo W; Xu B; Li M; Zhou Y; Rong Cui J
Anticancer Drugs; 2009 Nov; 20(10):926-31. PubMed ID: 19741503
[TBL] [Abstract][Full Text] [Related]
26. Drug sensitivity studies on clonal cell lines isolated from heteroploid tumor cell population. II. Sensitivity of clones growing in suspension cultures.
Pályi I
Neoplasma; 1980; 27(2):129-36. PubMed ID: 7393352
[TBL] [Abstract][Full Text] [Related]
27. [Use of 1,2:5,6-dianhydrogalactitol in combination with maytansine in experimental tumor therapy].
Fan YJ; Zhou J; Li M
Yao Xue Xue Bao; 1983 Sep; 18(9):648-53. PubMed ID: 6677049
[No Abstract] [Full Text] [Related]
28. Clinical trials with the hexitol derivatives in the U.S.
Chiuten DF; Rozencweig M; Von Hoff DD; Muggia FM
Cancer; 1981 Feb; 47(3):442-51. PubMed ID: 6784907
[TBL] [Abstract][Full Text] [Related]
29. Kinetics of growth inhibition in a neoplastic population after repeated cytostatic treatment.
Fremuth F; Vána B; Fabián F; Lánský P
Neoplasma; 1984; 31(2):157-64. PubMed ID: 6717685
[TBL] [Abstract][Full Text] [Related]
30. Phase II study of the combination of dianhydrogalactitol, doxorubicin, and cisplatin (DAP) in patients with advanced squamous cell lung cancer.
Eagan RT; Frytak S; Nichols WC; Ingle JN; Creagan ET; Kvols LK
Cancer Treat Rep; 1981; 65(5-6):517-9. PubMed ID: 7195306
[No Abstract] [Full Text] [Related]
31. Combination carmustine (BCNU) and dianhydrogalactitol in the treatment of primary brain tumors recurring after irradiation.
Eagan RT; Dinapoli RP; Hermann RC; Groover RV; Layton DD; Scott M
Cancer Treat Rep; 1982 Aug; 66(8):1647-9. PubMed ID: 7105055
[No Abstract] [Full Text] [Related]
32. Metastatic retinoblastoma and L-phenylalanine mustard-dianhydrogalactitol.
Helson L; Kitchin FD; Abramson D; Ellsworth RM
Anticancer Res; 1982; 2(4):235-8. PubMed ID: 7149653
[TBL] [Abstract][Full Text] [Related]
33. Tumor cell kinetics and cancer chemotherapy.
Toal DR
Crit Care Update; 1981 Sep; 8(9):34-7. PubMed ID: 6912803
[No Abstract] [Full Text] [Related]
34. In vitro and in vivo antitumor activity of methotrexate conjugated to human serum albumin in human cancer cells.
Wosikowski K; Biedermann E; Rattel B; Breiter N; Jank P; Löser R; Jansen G; Peters GJ
Clin Cancer Res; 2003 May; 9(5):1917-26. PubMed ID: 12738750
[TBL] [Abstract][Full Text] [Related]
35. Gas-chromatographic analysis for 1,2:5,6-dianhydrogalactitol, an anti-neoplastic agent, in plasma.
Kimura T; Sternson LA; Higuchi T
Clin Chem; 1976 Oct; 22(10):1639-43. PubMed ID: 975510
[TBL] [Abstract][Full Text] [Related]
36. Cell cycle and effect of antineoplastic drugs: facts and pitfalls.
Mauro F; Spanò M; Teodori L; Drewinko B; Barlogie B
Prog Clin Biol Res; 1983; 132C():199-209. PubMed ID: 6634772
[No Abstract] [Full Text] [Related]
37. Clinical and pharmacologic evaluation of split-dose intermittent therapy with dianhydrogalactitol.
Eagan RT; Ames MM; Powis G; Kovach JS
Cancer Treat Rep; 1982 Feb; 66(2):283-7. PubMed ID: 7034934
[TBL] [Abstract][Full Text] [Related]
38. Alkylation by 1,2:5,6-dianhydrogalactitol of deoxyribonucleic acid and guanosine.
Institóris E; Tamás J
Biochem J; 1980 Mar; 185(3):659-66. PubMed ID: 7387628
[TBL] [Abstract][Full Text] [Related]
39. [Radiosensitivity of nasopharyngeal carcinoma in relation to cell cycle synchronization effect of tumor necrosis factor alpha].
Yuan J; Sun N; Wang LJ; Tian W; Zhou XM; Chen DB; Gu HB
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):374-6. PubMed ID: 17425997
[TBL] [Abstract][Full Text] [Related]
40. Cell kinetic analysis of human tumor stem cells.
Durie BG; Salmon SE
Prog Clin Biol Res; 1980; 48():153-63. PubMed ID: 7208517
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
